103-LB: Real-World Persistence, Adherence, Health Care Resource Utilization, and Costs in People with Type 2 Diabetes (T2D) Switching from Basal Insulin (BI) to Second-Generation BI (Insulin Glargine 300 U/mL [Gla-300]) vs. First-Generation BI (Insulin Glargine 1

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 103-LB
Author(s):  
EUGENE WRIGHT ◽  
JASVINDER GILL ◽  
SAMUEL HUSE ◽  
XUAN LI ◽  
TIMOTHY REID ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document